Research HighlightsResearch Neurology Update: Dementia and cognitive disorders February 18, 2021 Longitudinal neuroimaging biomarkers differacross Alzheimer’s disease phenotypes Sintini et al investigated whether baseline and longitudinal patterns of tau-PET uptake and MRI grey matter volume loss mirror clinical phenotype in Alzheimer’s disease. Read more here. Neurology Update: Dementia and cognitive disorders was last modified: February 18th, 2021 by Anja BurlicaShare this...FacebookTwitterLinkedin previous post WFN Brain Health Awareness Public Webinar next post Neurology Update: Dementia and Cognitive Disorders You may also like Research Paper of the Month: Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic February 9, 2023 Sleep apnoea is a risk factor for severe COVID-19 February 3, 2021 Elevating knowledge in guidelines with popular workshop at EAN 2022 July 6, 2022 Research Highlights of the Month – May 2023 May 1, 2023 Breaking News: Surprising results of MOG-antibodies in pediatric demyelinating and encephalitic syndromes February 26, 2020 SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with COVID-19 December 2, 2020 COVID-19 among patients with epilepsy: Risk factors and course of the disease June 2, 2021 Interview with Teresinha Evangelista on the European Reference Networks – following the Meeting of the Rare Neurologic Diseases Task Force at EAN 2017 August 18, 2017 COVID-19 case fatality and Parkinson’s disease October 1, 2020 COVID-19, de novo seizures, and epilepsy: a systematic review December 2, 2020 Leave a Comment Cancel ReplyYou need to be logged in to comment. Please login to MyEAN on top.
